ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II study of losoxantrone (dup 941) in advanced breast cancer
European Journal of Cancer
◽
10.1016/0959-8049(93)91029-k
◽
1993
◽
Vol 29
◽
pp. S78
Author(s):
W. Ten Bokkel Muinink
◽
M. Moore
◽
I. Smith
◽
T. Vandenberg
◽
M. Barbu
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
Download Full-text
Related Documents
Cited By
References
346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover
European Journal of Cancer
◽
10.1016/0959-8049(95)95599-2
◽
1995
◽
Vol 31
◽
pp. S75
◽
Cited By ~ 1
Author(s):
R. Paridaens
◽
P. Bruning
◽
F. Calabresi
◽
A. Awada
◽
J.A. Roy
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
First Line
◽
Randomized Phase Ii
◽
Line Chemotherapy
Download Full-text
Megestrol acetate: Phase II study of a single daily administration in advanced breast cancer
Breast Cancer Research and Treatment
◽
10.1007/bf01812684
◽
1990
◽
Vol 17
(1)
◽
pp. 51-54
◽
Cited By ~ 9
Author(s):
Paolo Pronzato
◽
Fulvio Brema
◽
Domenico Amoroso
◽
Gianfilippo Bertelli
◽
Pier Franco Conte
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Megestrol Acetate
◽
Daily Administration
Download Full-text
Bromocriptin (B) and lanreotide (L) in advanced breast cancer: A phase II study
European Journal of Cancer
◽
10.1016/0959-8049(93)91067-u
◽
1993
◽
Vol 29
◽
pp. S84
◽
Cited By ~ 2
Author(s):
J. Bonneterre
◽
J.M. Plon
◽
A. Adenis
◽
J.P. Peyrat
◽
S. Henane
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
Download Full-text
Centchroman—a non-steroidal anti-cancer agent for advanced breast cancer: Phase-II study
International Journal of Cancer
◽
10.1002/ijc.2910430506
◽
1989
◽
Vol 43
(5)
◽
pp. 781-783
◽
Cited By ~ 39
Author(s):
N. C. Misra
◽
P. K. Nigam
◽
Ruby Gupta
◽
A. K. Agarwal
◽
V. P. Kamboj
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Anti Cancer
◽
Cancer Agent
Download Full-text
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
Annals of Oncology
◽
10.1093/annonc/mdi056
◽
2005
◽
Vol 16
(2)
◽
pp. 253-258
◽
Cited By ~ 59
Author(s):
L. Del Mastro
◽
F. Perrone
◽
L. Repetto
◽
L. Manzione
◽
V. Zagonel
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Weekly Paclitaxel
◽
Breast Cancer Patients
◽
First Line
◽
Line Chemotherapy
Download Full-text
Vinorelbine as second line treatment in anthracycline pre-treated advanced breast cancer patients: A phase II study
European Journal of Cancer
◽
10.1016/0959-8049(93)91052-m
◽
1993
◽
Vol 29
◽
pp. S82
◽
Cited By ~ 4
Author(s):
L. Dogliotti
◽
G. Gorzegno
◽
M.G. Bau
◽
A. Farris
◽
C. Bumma
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Line Treatment
◽
Second Line
◽
Breast Cancer Patients
Download Full-text
A phase II study of 4-deoxydoxorubicin in advanced breast cancer
European Journal of Cancer and Clinical Oncology
◽
10.1016/0277-5379(87)90363-4
◽
1987
◽
Vol 23
(7)
◽
pp. 1079-1080
◽
Cited By ~ 1
Author(s):
Elaine M. Rankin
◽
Robert K. Knight
◽
Robert D. Rubens
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
Download Full-text
Cisplatin — epirubicin — paclitaxel (PET) weekly administration with G-CSF support in advanced breast cancer (ABC). A phase II study
European Journal of Cancer
◽
10.1016/s0959-8049(99)81693-1
◽
1999
◽
Vol 35
◽
pp. S318
◽
Cited By ~ 1
Author(s):
G. Frasci
◽
P. Comella
◽
G. D'Aiuto
◽
A. Apicella
◽
R. Thomas
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Weekly Administration
Download Full-text
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-18-0613
◽
2018
◽
Vol 24
(18)
◽
pp. 4380-4387
◽
Cited By ~ 26
Author(s):
Maura N. Dickler
◽
Cristina Saura
◽
Donald A. Richards
◽
Ian E. Krop
◽
Andrés Cervantes
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
Advanced Breast
◽
Hormone Receptor Positive
Download Full-text
A Phase II Study (FINDER 2) Comparing Three Dosing Regimens of Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer.
10.1158/0008-5472.sabcs-09-4095
◽
2009
◽
Author(s):
K. Pritchard
◽
J. Rolski
◽
Z. Pápai
◽
L. Mauriac
◽
F. Cardoso
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Advanced Breast Cancer
◽
Postmenopausal Women
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Estrogen Receptor Positive
◽
Dosing Regimens
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close